Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 16 | 30993491 | splice region variant | T/C | snv | 0.39 | 0.38 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | ||||||
|
1.000 | 16 | 30993375 | missense variant | A/T | snv |
|
0.800 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
1.000 | 16 | 30993240 | missense variant | C/G | snv |
|
0.800 | 0 | |||||||||||||
|
16 | 30996983 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 3 | 1993 | 2016 | ||||||||||
|
16 | 30996983 | missense variant | C/A | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 3 | 1993 | 2016 | ||||||||||
|
0.925 | 0.040 | 16 | 30993491 | splice region variant | T/C | snv | 0.39 | 0.38 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
16 | 31000500 | intron variant | T/G | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 16 | 30989488 | 3 prime UTR variant | G/A;C | snv | 0.52 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 16 | 30989488 | 3 prime UTR variant | G/A;C | snv | 0.52 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
16 | 30995651 | intron variant | C/T | snv | 0.37 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 30995651 | intron variant | C/T | snv | 0.37 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
16 | 30999862 | intron variant | A/G | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
16 | 30999862 | intron variant | A/G | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 31004556 | intron variant | C/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 30991399 | 3 prime UTR variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
16 | 30991343 | 3 prime UTR variant | A/G | snv | 0.62 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 30991343 | 3 prime UTR variant | A/G | snv | 0.62 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 16 | 31001165 | protein altering variant | -/CAATGCACATCC | ins |
|
0.700 | 0 | |||||||||||||
|
16 | 31001195 | splice acceptor variant | T/C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||||
|
1.000 | 16 | 31001597 | frameshift variant | -/TT | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 16 | 31001159 | stop gained | G/A;T | snv | 2.8E-05 |
|
0.700 | 0 | ||||||||||||
|
1.000 | 16 | 31001133 | stop gained | G/A | snv |
|
0.700 | 0 | |||||||||||||
|
16 | 30993183 | stop gained | G/A;C | snv | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 |